Literature DB >> 31247314

Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen.

Adrienne D Mishkin1, Peter A Shapiro2, Ran Reshef3, Sara Lopez-Pintado4, Markus Y Mapara3.   

Abstract

In patients undergoing stem cell transplantation (SCT), nonadherence has potential for significant medical impact and potentially life-threatening complications. No study thus far has demonstrated an effective way to predict adherence in SCT recipients. A structured rating scale, the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT), has been shown to predict psychosocial outcomes and medical morbidity in solid organ transplant recipients. We assessed the SIPAT in SCT recipients. We hypothesized that the SIPAT rating would be associated with nonadherence to the post-SCT regimen. We retrospectively studied SCT recipients who had psychiatric evaluations with the SIPAT before SCT. The primary outcome was nonadherence, defined a priori as at least 1 life-threatening nonadherence event in the first 6 months post-transplant. Association of the SIPAT with outcomes was evaluated by logistic regression, and an optimal cutoff score was determined using a receiver operating characteristic curve. Of 85 patients (mean age 47 years; range, 18 to 74 years), 56 (66%) were male, and 43 (50.5%) received autologous SCT. Eighteen (21%) patients were nonadherent. The SIPAT rating, treated as a continuous variable and controlling for autologous versus allogeneic SCT, was significantly associated with nonadherence (per 1 point; odds ratio [OR], 1.162; P< .0001). Allogeneic SCT also conferred a significantly increased risk of nonadherence (OR, 14.184; P= .005). Multivariate analysis stratifying for allogeneic versus autologous transplantation and controlling for age, sex, and disease confirmed an independent association between the SIPAT score and nonadherence. A cutoff score of 18 provided optimal specificity (89.6%) and sensitivity (55.6%) for nonadherence. Nonadherence rates were 58.8% and 11.8% for subjects with SIPAT ratings of 18 and above or 17 and below, respectively (relative risk = 4.98, P < .0001). Psychosocial risk as quantified by the SIPAT correlated with SCT recipients' adherence to the post-transplant regimen, suggesting that this instrument can contribute to medical risk stratification models. Further study should evaluate long-term mortality data and the effects of intervention on psychosocial risks.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adherence; SIPAT; Stem Cell transplant

Year:  2019        PMID: 31247314     DOI: 10.1016/j.bbmt.2019.06.019

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  Use of the Stanford Integrative Psychosocial Assessment for Transplant as a Pre-surgical Psychological Evaluation Tool for Bariatric Surgery.

Authors:  Stephanie E Punt; Ashley C Rhodes; Stephen S Ilardi; Jessica L Hamilton
Journal:  J Clin Psychol Med Settings       Date:  2022-01-24

2.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.

Authors:  Donna M Posluszny; Dana H Bovbjerg; Karen L Syrjala; Mounzer Agha; Rafic Farah; Jing-Zhou Hou; Anastasios Raptis; Annie P Im; Kathleen A Dorritie; Michael M Boyiadzis; Mary Amanda Dew
Journal:  Transplant Cell Ther       Date:  2021-12-04

4.  Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study.

Authors:  Rahul Banerjee; Chiung-Yu Huang; Lisa Dunn; Jennifer Knoche; Chloe Ryan; Kelly Brassil; Lindsey Jackson; Dhiren Patel; Mimi Lo; Shagun Arora; Sandy W Wong; Jeffrey Wolf; Thomas Martin Iii; Anand Dhruva; Nina Shah
Journal:  JMIR Form Res       Date:  2022-03-04

5.  Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.

Authors:  Rahul Banerjee; Jean C Yi; Navneet S Majhail; Heather S L Jim; Joseph Uberti; Victoria Whalen; Alison W Loren; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-08       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.